(Q36793779)

16 August 2017

Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy (English)

1 reference

16 August 2017

1 reference

1 reference

Florentia Peintinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Bruno Sinn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Constance Albarracin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jerzy Morkowski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Rebekah Gould

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

W Fraser Symmans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

1 May 2015

1 reference

16 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

913-920

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

10 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

An international Ki67 reproducibility study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

Overall concordance correlation coefficient for evaluating agreement among multiple observers.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4830087

Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors

5 September 2018

1 reference

12 December 2020

Facilitating consensus by examining patterns of treatment effects

1 reference

12 December 2020

Measurement of residual disease after neoadjuvant chemotherapy

1 reference

12 December 2020

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

12 December 2020

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

12 December 2020

10.1038/MODPATHOL.2015.53

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

25932963

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25932963%20AND%20SRC:MED&resulttype=core&format=json